Biblio Discovery — Demo Discovery Service

19 results for "Lin shen"

Showing 1–19 · 0.65 seconds · RSS

  1. Journal Article Full text

    3D printing of conducting polymers

    Hyunwoo Yuk; Baoyang Lu; Lin Shen et al.

    Nature Communications · 2020 · English · OpenAlex Scopus

    Conducting polymers are promising material candidates in diverse applications including energy storage, flexible electronics, and bioelectronics. However, the fabrication of conducting polymers has mostly relied on conventional approaches such as ink-jet printing, screen printing, and electron-beam…

  2. Journal Article

    Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

    Feng‐Hua Wang; Xiaoli Wei; Jifeng Feng et al.

    Journal of Clinical Oncology · 2021 · English · OpenAlex Scopus

    PURPOSE As yet, no checkpoint inhibitor has been approved to treat nasopharyngeal carcinoma (NPC). This study was aimed to evaluate the antitumor activity, safety, and biomarkers of toripalimab, a new programmed death-1 (PD-1) inhibitor for recurrent or metastatic NPC (RM-NPC) refractory to…

  3. Journal Article Full text

    Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

    Changsong Qi; Jifang Gong; Jian Li et al.

    Nature Medicine · 2022 · English · OpenAlex Scopus

    Abstract Despite success in hematologic malignancies, the treatment landscape of chimeric antigen receptor (CAR) T cell therapy for solid tumors remains limited. Claudin18.2 (CLDN18.2)-redirected CAR T cells showed promising efficacy against gastric cancer (GC) in a preclinical study. Here we…

  4. Journal Article Full text

    Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

    Manish A. Shah; Kohei Shitara; Jaffer A. Ajani et al.

    Nature Medicine · 2023 · English · OpenAlex Scopus

    There is an urgent need for first-line treatment options for patients with human epidermal growth factor receptor 2 (HER2)-negative, locally advanced unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma. Claudin-18 isoform 2 (CLDN18.2) is expressed in normal…

  5. Journal Article Full text

    Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

    Zhihao Lü; Junye Wang; Yongqian Shu et al.

    BMJ · 2022 · English · OpenAlex Scopus

    Abstract Objective To evaluate sintilimab versus placebo in combination with chemotherapy (cisplatin plus paclitaxel or cisplatin plus 5-fluorouracil) as first line treatment of unresectable locally advanced, recurrent, or metastatic oesophageal squamous cell carcinoma. Design Multicentre…

  6. Journal Article Full text

    First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial

    Yelena Yuriy Janjigian; Jaffer A. Ajani; Markus Hermann Moehler et al.

    Journal of Clinical Oncology · 2024 · English · OpenAlex Scopus

    Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate…

  7. Journal Article Full text

    Prevalence of Osteoporosis and Fracture in China

    Lınhong Wang; Wei Yu; Xiangjun Yin et al.

    JAMA Network Open · 2021 · English · OpenAlex Scopus

    Importance: The aging of the population is associated with an increasing burden of fractures worldwide. However, the epidemiological features of fractures in mainland China are not well known. Objective: To assess the prevalence of and factors associated with osteoporosis, clinical fractures, and…

  8. Journal Article Full text

    Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

    Kohei Shitara; Jaffer A. Ajani; Markus Hermann Moehler et al.

    Nature · 2022 · English · OpenAlex Scopus

    Abstract Standard first-line chemotherapy results in disease progression and death within one year in most patients with human epidermal growth factor receptor 2 (HER2)-negative gastro-oesophageal adenocarcinoma 1–4 . Nivolumab plus chemotherapy demonstrated superior overall survival versus…

  9. Journal Article Full text

    Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

    Lin Shen; Ken Kato; Sung‐Bae Kim et al.

    Journal of Clinical Oncology · 2022 · English · OpenAlex Scopus

    PURPOSE Patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC) have poor prognosis. For these patients, treatment options are limited after first-line systemic therapy. PATIENTS AND METHODS In this open-label phase III clinical study, patients with advanced or metastatic…

  10. Journal Article Full text

    The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

    Feng‐Hua Wang; Xiao‐Tian Zhang; Yuanfang Li et al.

    癌症:英文版 · 2021 · English · OpenAlex

    Abstract There exist differences in the epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selections between gastric cancer patients from the Eastern and Western countries. The Chinese Society of Clinical Oncology (CSCO)…

  11. Journal Article Full text

    The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

    Feng‐Hua Wang; Xiao‐Tian Zhang; Lei Tang et al.

    癌症:英文版 · 2023 · English · OpenAlex

    The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in evidence-based medicine, healthcare resource availability, and precision medicine. These…

  12. Journal Article Full text

    Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

    Zixian Wang; Chengxu Cui; Jun Yao et al.

    Cancer Cell · 2022 · English · OpenAlex Scopus

    Platinum-based chemotherapy is the standard first-line treatment for advanced esophageal squamous cell carcinoma (ESCC). In this phase 3 study (ClinicalTrial.gov: NCT03829969), 514 patients with treatment-naïve advanced ESCC were randomized (1:1) to receive toripalimab or placebo in combination…